Company Profile

Acelot Inc
Profile last edited on: 1/10/17      CAGE: 4J8Q7      UEI: CC15RKJHFRE1

Business Identifier: drug discovery algorithm finding effective disease-modifying therapies with minimal side-effects for central nervous system diseases such as Alzheimer's and Parkinson's Disease.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5385 Hollister Avenue Suite 111
Santa Barbara, CA 93111
   (805) 617-3610
Location: Single
Congr. District: 24
County: Santa Barbara

Public Profile

Acelot Inc is a drug development company applying patented searching and mining algorithms to complex biological and chemical data to discover new leads for central nervous system diseases, including Alzheimer's and Parkinson's, and various types of cancer. The firm’s ability to analyze large biological pathways opens up new and previously unknown options for drug targets. Acelot's unique graph-based in-silico algorithm approach results in small molecule leads that are tailored to biological targets and screen against undesired targets, minimizing the risk of side-effects.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2016 1 NIH $223,325
Project Title: Discovery of Lxr Agonists Via Pharmacophore Space Mining
2014 1 NSF $150,000
Project Title: A Learning Drug Discovery Platform in the Cloud
2012 1 NIH $183,000
Project Title: Discovery Of A-Beta Oligomer Antagonists Via 3d Pharmacophore Space Analysis
2011 1 NSF $150,000
Project Title: Identifying Drug Leads via 3D Pharmacophore Space Analysis
2010 2 NIH $1,346,534
Project Title: Scalable tools for the analysis of chemical compounds using graph-based querying

Key People / Management

  Ambuj Kumar Singh -- President; Chief Executive Officer

  Stuart C Feinstein -- Scientific Advisor

  Christian Lang -- Chief Technology Officer

  William Maxwell Lindstrom

  Prakash Natarajan -- Applications Developer

  Gilbert M Rishton -- Scientific Advisor

Company News

There are no news available.